tailieunhanh - báo cáo khoa học: "Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài:Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study | BioMed Central Journal of Hematology Oncology Research Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients a prospective cohort study Rakshit Panwar 1 2 Bala Venkatesh2 3 4 Peter Kruger2 Robert Bird5 Devinder Gill5 Leo Nunnink2 and Goce Dimeski6 Address 1Intensive Care Monash Medical Centre Clayton VIC 3168 Australia intensive Care Princess Alexandra Hospital Princess Alexandra Hospital Brisbane Australia intensive Care Wesley Hospital Brisbane Australia 4Department of Intensive Care University of Queensland Brisbane Australia 5Department of Hematology Princess Alexandra Hospital Brisbane Australia and 6Department of Chemical Pathology Princess Alexandra Hospital Brisbane Australia Email Rakshit Panwar - rakshitpanwar@ Bala Venkatesh - bala_venkatesh@ Peter Kruger - peter_kruger@ Robert Bird - robert_bird@ Devinder Gill - devinder_gill@ Leo Nunnink - leo_nunnink@ Goce Dimeski - goce_dimeski@ Corresponding author Open Access Published 19 October 2009 Received 6 August 2009 Journal of Hematology Oncology 2009 2 43 doi 1756-8722-2-43 Accepted 19 October 2009 This article is available from http content 2 1 43 2009 Panwar et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Introduction Activated Protein C APC improves outcome in immunocompetent patients with severe sepsis particularly in those who are perceived to have high mortality risk. Before embarking on a trial of APC administration in immunocompromised septic patients a preliminary study on plasma levels of protein C in this cohort is essential. Objective